Adam Miller, JD, MBA, built Cornerstone OnDemand from his one-bedroom apartment to a multi-billion dollar global public company (NASDAQ: CSOD) which now helps over 75 million people around the world to realize their potential. 

Adam is the Managing Partner of 1P Ventures, which has funded over 20 early- and mid-stage technology, healthcare and biotech companies. Adam was a seed investor in Aimmune Therapeutics (NASDAQ: AIMT). 

Adam is an avid social entrepreneur. He led the merger of FAAN and FAI to create FARE, the nation’s leading food allergy volunteer health organization. He also has helped build UCLA’s Food Allergy Program. Adam is chairman of Team Rubicon, a leading humanitarian aid organization and America’s largest veteran’s service organization with over 120,000 volunteers, and he chairs the Cornerstone Foundation, which has delivered over $150M of social impact in the last decade. 

Prior to founding Cornerstone, Adam served time as an investment banker and consultant. He holds a BA from the University of Pennsylvania, a BS from its Wharton School of Business, a JD from the UCLA School of Law, an MBA from UCLA’s Anderson School of Business, and has both CPA and Series 7 certifications. Adam lives in Los Angeles with his wife and three children, including a son with food allergies.